Current Edition

Delivering Viable, High-quality Leukapheresis Product
Volume 3 Issue 2

Delivering Viable, High-quality Leukapheresis Product via Advanced Cold Storage Solutions

Fresh leukapheresis product (LP) is a critical raw material in the global biopharmaceutical industry, being essential across many primary cell research and therapy development applications. …

Continue Reading →
Exosome Therapeutics
Volume 3 Issue 2

Exosome Therapeutics: Academic Curiosity or Commercial Reality?

Cell and gene therapies have been called the emerging fourth pillar of healthcare systems. However, recent research suggests that the cell therapy pillar may, in …

Continue Reading →
Non-clinical Safety Evaluation of Vaccine Strategic
Volume 3 Issue 2

Non-clinical Safety Evaluation of Vaccine: Strategic Considerations to Accelerate Clinical Development

Vaccines are medicinal products intended to elicit (an) immune response(s) that can prevent (prophylactic vaccine) and/or lessen the severity (therapeutic vaccine) of a given disease. …

Continue Reading →
Accelerating Regenerative Medicine Approaches to Type 1
Volume 3 Issue 2

Accelerating Regenerative Medicine Approaches to Type 1 Diabetes Through Direct Cell Reprogramming

Current treatment of type 1 diabetes mellitus (T1DM) depends on the replacement of endogenous insulin by regular subcutaneous injections of exogenous insulin. Unfortunately, exogenous insulin …

Continue Reading →
Analysing Carbohydrates with Ion Chromatography
Volume 3 Issue 2

Analysing Carbohydrates with Ion Chromatography to Develop Better Vaccines

In vaccine research, where reproducibility and accuracy are of paramount importance, scientists will need to choose the most appropriate technique to examine and characterise carbohydrates …

Continue Reading →